Egypt: Arab Drug Company’s profits soar 121% YoY in FY23/24

Net profits after tax recorded EGP 100.48 million last FY, up from EGP 82.77 million a year earlier

Staff Writer, Arab Finance

July 31, 2024

PHOTO

Arab Drug Company’s (ADCI) net profits after tax jumped 121% year on year (YoY) in the fiscal year (FY) 2023/2024, according to the company’s financial indicators.

Net profits after tax recorded EGP 100.48 million last FY, up from EGP 82.77 million a year earlier.

Meanwhile, total revenues rose to EGP 785.522 million from EGP 633.733 million.

Arab Drug is an Egypt-based company engaged in the pharmaceutical sector. The company focuses on the manufacture, packaging, and distribution of pharmaceutical products as well as chemical solutions for human and veterinary use.

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.